CSIMarket
 


Respirerx Pharmaceuticals Inc   (RSPI)
Other Ticker:  
 

Respirerx Pharmaceuticals Inc 's Total Debt to Equity

RSPI's quarterly Total Debt to Equity and Total Debt, Equity growth


In II Quarter 2023 Respirerx Pharmaceuticals Inc had stockholder deficit.

Within Major Pharmaceutical Preparations industry Respirerx Pharmaceuticals Inc achieved the lowest Total Debt to Equity in the second quarter 2023. While total ranking remained the same in the second quarter 2023 compared to the previous quarter at no. .

Explain Debt to Equity Ratio?
What is the structure of RSPI´s Total Debt?
How valuable is the RSPI´s Equity?


RSPI Total Debt to Equity (Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
Y / Y Equity Change - - - - -
Y / Y Total Debt Change -23.1 % -28.32 % 56.25 % 103.66 % 152.11 %
Total Debt to Equity MRQ - - - - -
RSPI's Total Ranking # # # # #
Seq. Equity Change - - - - -
Seq. Total Debt Change 0.25 % -35.02 % 3.71 % 13.82 % -6.56 %



Total Debt to Equity second quarter 2023 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #


Total Debt to Equity Statistics
High Average Low
0 0 0
 




Financial Statements
Respirerx Pharmaceuticals Inc 's Equity $ -12 Millions Visit RSPI's Balance sheet
Respirerx Pharmaceuticals Inc 's Total Debt $ 1 Millions Visit RSPI's Balance sheet
Source of RSPI's Sales Visit RSPI's Sales by Geography


Cumulative Respirerx Pharmaceuticals Inc 's Total Debt to Equity

RSPI's Total Debt to Equity for the trailling 12 Months

RSPI Total Debt to Equity

(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
Y / Y Equity TTM Growth - - - - -
Y / Y Total Debt TTM Growth -23.1 % -28.32 % 56.25 % 103.66 % 152.11 %
Total Debt to Equity TTM - - - - -
Total Ranking TTM
Seq. Equity TTM Growth - - - - -
Seq. Total Debt TTM Growth 0.25 % -35.02 % 3.71 % 13.82 % -6.56 %


On the trailing twelve months basis During the 12 months period ending II Quarter 2023 company had stockholder deficit.
Total Debt to Equity is the average cumulative value over the last four quarters.

Among companies in the Major Pharmaceutical Preparations industry RSPI recorded the lowest Total Debt to Equity. While total ranking remained unchanged compared to previous 12 month period at no. 0.

Explain Debt to Equity Ratio?
What is the structure of RSPI´s Total Debt?
How valuable is the RSPI´s Equity?

TTM Total Debt to Equity Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Within the Market #


trailing twelve months Total Debt to Equity Statistics
High Average Low
0 0 0
 




Companies with similar Total Debt to Equity in the quarter ending Jun 30 2023, within Major Pharmaceutical Preparations Industry Total Debt to EquityJun 30 2023 MRQ Total DebtJun 30 2023 MRQ Equity

Date modified: 2023-08-25T21:47:42+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com